Clinical activity of anti-Gram-positive agents against methicillin-resistant Staphylococcus aureus | Zendy

I.M. Gould | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Clinical activity of anti-Gram-positive agents against methicillin-resistant Staphylococcus aureus

Author(s) -

I.M. Gould

Publication year - 2011

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dkr073

Subject(s) - staphylococcus aureus , vancomycin , antibiotics , glycopeptide , microbiology and biotechnology , gram , medicine , methicillin resistant staphylococcus aureus , bacteria , biology , genetics

Current concerns about multiresistance and a diminishing antibiotic pipeline are mainly addressed to Gram-negative bacteria. The greatest fear within the Gram-positive arena is vancomycin-resistant Staphylococcus aureus. Its epidemiology and clinical presentation give cause for concern, but so far its impact has been strictly limited. While this may change, the loss of glycopeptides as a treatment option may not, in fact, be all bad news.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research